Keith Berelowitz

Keith has spent more than 25 years working across science, clinical research, patient engagement and human decision-making.

Originally trained as a scientist, he went on to serve in multiple roles within a major clinical trials unit in London, working across hundreds of studies and seeing clinical research from the inside: the science, the operations, the pressures on sites and, most importantly, the experience of the people being asked to take part.

Over time, that experience led him to question one of the assumptions sitting at the heart of clinical research: that deciding whether someone should participate in a trial is primarily a question of medical eligibility.

Keith’s work increasingly draws on behavioral science to flip that script.

Medical eligibility matters, but it is only part of the decision. A person may be medically suitable for a study while the study itself is completely unsuitable for their life. Time, routines, family support, work, travel, emotional readiness, motivation and practical burden can all determine whether participation is realistic and whether someone is likely to have a strong experience once they enter a trial.

That thinking now sits at the center of his work as founder and CEO of trialport, a platform designed to help people understand clinical trials, consider what participation would actually mean for them, and make more informed decisions about whether a particular study fits both their health and their life.

Keith writes about clinical research, behavioral science, decision-making, technology and the systems we build around people. He is particularly interested in what happens when efficiency, data and automation collide with human judgment, understanding and individual circumstance.

His central belief is simple: better clinical research starts by understanding the person, not simply determining whether they meet the protocol.

Understanding comes first. Decisions follow.